Open AccessSex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease
Author(s) -
Zuzana Zelinková
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i47.6967
Subject(s) - medicine , infliximab , ulcerative colitis , inflammatory bowel disease , adalimumab , discontinuation , adverse effect , medical record , crohn's disease , adverse drug reaction , gastroenterology , disease , drug , pharmacology
To analyze sex differences in adverse drug reactions (ADR) to the immune suppressive medication in inflammatory bowel disease (IBD) patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom